Generex Biotechnology Corporation

Informe acción OTCPK:GNBT

Capitalización de mercado: US$61.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Generex Biotechnology Dirección

Dirección controles de criterios 2/4

Información clave

Joe Moscato

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO5.4yrs
Participación del CEO0.4%
Permanencia media de la dirección5.4yrs
Promedio de permanencia en la Junta Directiva5.4yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Joe Moscato en comparación con los beneficios de Generex Biotechnology?
FechaCompensación totalSalarioIngresos de la empresa
Apr 30 2021n/an/a

-US$37m

Jan 31 2021n/an/a

-US$52m

Oct 31 2020n/an/a

-US$35m

Jul 31 2020US$623kUS$623k

-US$33m

Apr 30 2020n/an/a

-US$26m

Jan 31 2020n/an/a

-US$31m

Oct 31 2019n/an/a

-US$36m

Jul 31 2019US$103kn/a

-US$9m

Apr 30 2019n/an/a

US$10m

Jan 31 2019n/an/a

US$24m

Oct 31 2018n/an/a

US$27m

Jul 31 2018US$100kn/a

US$36m

Apr 30 2018n/an/a

US$9m

Jan 31 2018n/an/a

-US$37m

Oct 31 2017n/an/a

-US$43m

Jul 31 2017US$50kn/a

-US$70m

Compensación vs. Mercado: Insufficient data to establish whether Joe's total compensation is reasonable compared to companies of similar size in the US market.

Compensación vs. Ingresos: Joe's compensation has increased whilst the company is unprofitable.


CEO

Joe Moscato (57 yo)

5.4yrs

Permanencia

US$623,082

Compensación

Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Mark Corrao
CFO & Treasurer5.4yrsUS$10.00k0%
$ 0
Terry Thompson
Chief Operating Officer4.4yrsUS$566.44k0%
$ 0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Anthony Crisci
Chief Legal Officer & Chief Administrative Officer2.8yrsUS$424.83k0%
$ 0
Anthony Dolisi
Chief Commercial Officer3.4yrssin datos1.08%
$ 658.9
Jason Terrell
Chief Scientific Officer & Chief Medical Officer5.4yrssin datos0%
$ 0
Michelle Starr
Chief Marketing Officer3.6yrssin datossin datos
Richard Purcell
Executive Vice President of Research & Drug Development5.4yrsUS$68.33k0%
$ 0

5.4yrs

Permanencia media

56.5yo

Promedio de edad

Equipo directivo experimentado: GNBT's management team is seasoned and experienced (5.4 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Brian McGee
Independent Director18.3yrsUS$47.20k0%
$ 0
Lawrence Salvo
Independent Director5.4yrsUS$18.88k0.26%
$ 160.2
Craig Eagle
Independent Director & Member of Scientific Advisory Board11.8yrsUS$47.20k0%
$ 0
James Anderson
Independent Director11yrsUS$118.33k0%
$ 0
Gary Noel
Member of Scientific Advisory Board1.7yrssin datossin datos
Mark Prioletti
Independent Director3.2yrssin datos0%
$ 0
John Sanders
Member of Scientific Advisory Board1.7yrssin datossin datos
Jonathan Davis
Member of Scientific Advisory Board1.7yrssin datossin datos

5.4yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: GNBT's board of directors are considered experienced (5.4 years average tenure).